Robyn Domsic MD
Scleroderma & Related
Associate Professor, Medicine, University of Pittsburgh School of Medicine
Join to View Full Profile
3601 Fifth AvenuePittsburgh, PA 15213
Phone+1 412-647-3087
Fax+1 412-647-5551
Dr. Domsic is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UPMC Medical EducationFellowship, Rheumatology, 2004 - 2006
Duke University HospitalResidency, Internal Medicine, 2001 - 2004
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2001
Certifications & Licensure
PA State Medical License 2004 - 2026
NC State Medical License 2001 - 2004
American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2017
- CMS Meaningful Use Stage 1 Certification dbMotion, dbMotion Inc., 2012-2017
Clinical Trials
- Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients Start of enrollment: 2005 Feb 01
- Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) Start of enrollment: 2011 Jun 24
- Safety and Tolerability of Pirfenidone in Participants With Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) (LOTUSS) Start of enrollment: 2013 Oct 01
Publications & Presentations
PubMed
- Gain of function NOTCH4 variants disrupt angiogenesis in systemic sclerosis.Urvashi Kaundal, Pei-Suen Tsou, Mousumi Sahu, Mengqi Huang, Steven E Boyden
Annals of the Rheumatic Diseases. 2026-02-04 - 1 citationsExploiting a unified vascular framework to predict organ-specific complications and accomplish disease modification in systemic sclerosis.John D Pauling, Yannick Allanore, Maya H Buch, Maurizio Cutolo, Francesco Del Galdo
The Lancet. Rheumatology. 2025-12-01 - Combining Pirfenidone With Mycophenolate Mofetil for Systemic Sclerosis-Related Interstitial Lung Disease (Scleroderma Lung Study III): An Investigator-Initiated, Mult...Dinesh Khanna, Cathie Spino, Donald P Tashkin, Elana J Bernstein, Jonathan Goldin
ACR Open Rheumatology. 2025-12-01
Journal Articles
- Anti‐RNPC3 (U11/U12) Antibodies in Systemic Sclerosis Are Associated with Moderate to Severe Gastrointestinal DysmotilityRobyn T Domsic, Ami A Shah, Thomas A Medsger, Zsuzsanna H McMahan, Arthritis Care & Research
- Serum Biomarker for Diagnostic Evaluation of Pulmonary Arterial Hypertension in Systemic SclerosisHarrison W Farber, Kari Roberts, Nicholas Hill, Robyn Domsic, Robert W Simms, BioMed Central
Press Mentions
Study Seeks Autoimmune Disease Patients to Test COVID-19 VaccinesSeptember 21st, 2021
Riociguat in Scleroderma Associated Digital Ulcers (RESCUE)September 22nd, 2016
UPMC Physician ResourcesFebruary 29th, 2016
Grant Support
- Developing Clinical Risk Predictions Rules In Early Diffuse SchlerodermaNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2009–2012
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
